Thanks to their much-lauded potential in treating a variety of debilitating diseases, and their recent isolation, human embryonic stem (ES) cells1 have been the focus of a great deal of attention over the past several months. And yet we are startlingly ignorant of the biology of stem cells and their differentiation; an intimate appreciation of these is required to realize therapeutic aspirations. A timely meeting * in mid-April brought together investigators with expertise in stem cell biology and developmental biology of the pancreas as a first step to harness stem cells in the treatment of diabetes.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Notes
*Stem Cells and Pancreatic Development. National Institutes of Health, Bethesda, Maryland, April 10-11, 2000
References
Thomson, J.A. et al. Science 282, 1145– 1147 (1998).
Bonner-Weir, S., Baxter, L.A., Schuppin, G.T. & Smith, F.E. Diabetes 42, 1715–1720 (1993).
Gu, D. & Sarvetnick, N. Recent Prog. Horm. Res. 49, 161–165 (1994).
Jensen, J. et al. Diabetes 49, 163–176 (2000).
Gradwohl, G., Dierich, A., LeMeur, M. & Guillemot, F. Proc. Natl Acad. Sci. USA 97, 1607–1611 (2000).
Apelqvist, Å. et al. Nature 400, 877–881 (1999).
Jensen, J. et al. Nature Genetics 24, 3– 44 (2000).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Serup, P. Panning for pancreatic stem cells. Nat Genet 25, 134–135 (2000). https://doi.org/10.1038/75960
Issue Date:
DOI: https://doi.org/10.1038/75960
This article is cited by
-
Morphogenetic plasticity of adult human pancreatic islets of Langerhans
Cell Death & Differentiation (2005)